Does a symptom management intervention affect depression among cancer patients: Results from a clinical trial

Cancer patients diagnosed with solid tumors and undergoing a first course of chemotherapy were randomized to either conventional care or a 10 contact 20 week cognitive behavioral intervention designed to reduce emotional distress. Three hypotheses were tested. First, a test for a group effect found...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Psycho-oncology (Chichester, England) England), 2004-11, Vol.13 (11), p.818-830
Hauptverfasser: Given, Charles, Given, Barbara, Rahbar, Mohammad, Jeon, Sangchoon, McCorkle, Ruth, Cimprich, Bernadine, Galecki, Andrez, Kozachik, Sharon, Devoss, Danielle, Brady, Albert, Fisher-Malloy, Mary Jo, Courtney, Kathy, Bowie, Elizabeth
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 830
container_issue 11
container_start_page 818
container_title Psycho-oncology (Chichester, England)
container_volume 13
creator Given, Charles
Given, Barbara
Rahbar, Mohammad
Jeon, Sangchoon
McCorkle, Ruth
Cimprich, Bernadine
Galecki, Andrez
Kozachik, Sharon
Devoss, Danielle
Brady, Albert
Fisher-Malloy, Mary Jo
Courtney, Kathy
Bowie, Elizabeth
description Cancer patients diagnosed with solid tumors and undergoing a first course of chemotherapy were randomized to either conventional care or a 10 contact 20 week cognitive behavioral intervention designed to reduce emotional distress. Three hypotheses were tested. First, a test for a group effect found that patients in the intervention who entered the trial with higher symptom severity reported significantly lower depression at 10 but not 20 weeks. Patients in the experimental group who entered with higher depression were more depressed at 10 weeks than patients in the control group. The second hypothesis compared the intervention in two sub‐indices of symptom severity; one comprised of symptoms with a depressive component, the other of symptoms not associated with depression. The intervention was more effective in lowering depression at 10 weeks through an interaction with the non‐depressive symptom sub‐index. At 20 weeks, a significant main effect for the intervention on depression was observed. No interaction with either sub‐index was observed. The third hypothesis found no main or interaction effect between psychotropic drugs and the intervention. In conclusion, behavioral interventions may influence depression differently over time. Initially, the intervention lowered depression through certain symptoms and only later did it effect depression directly. Symptoms with an affective component are relatively unaffected by the intervention which was independent of the presence of psychotropic medications. Copyright © 2004 John Wiley & Sons, Ltd.
doi_str_mv 10.1002/pon.807
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_764236028</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67096295</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4417-a64d4d123c0fc7c0522c7d4268520e0b8e93d0491f02344058ed22a0516476b63</originalsourceid><addsrcrecordid>eNqF0dFqFDEUBuAgiq2r-AYSvNALmXqSySQzvZNq19KyLaJ4GbKZMyV1JjMmGXXfvll3sVBQr3IIHz85-Ql5zuCIAfC30-iPalAPyCGDpimYZOzhdq5U0XDRHJAnMd4AZNvIx-SAVWUtVQOHZHg_YqSGxs0wpXGgg_HmGgf0iTqfMPzIkxs9NV2HNtEWp4Ax_r4ZRn9NrfEWA51MclnGY_oJ49ynSLuQ0wy1vfPOmp6m4Ez_lDzqTB_x2f5ckC-nHz6ffCwuLpdnJ-8uCisEU4WRohUt46WFzioLFedWtYLLuuKAsK6xKVsQDeuAl0JAVWPLuYGKSaHkWpYL8nqXO4Xx-4wx6cFFi31vPI5z1EoKXkrgdZav_imlyj_Gm-q_sFKsZtvYBXl5D96Mc_B5Xc05V7IEUd890IYxxoCdnoIbTNhoBnrbqM6N6txoli_2cfN6wPbO7SvM4M0O_HQ9bv6Wo68uV7u4YqddTPjrjzbhW161VJX-ulpqJa7Y8vx8pVV5C5T_t3w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>222763048</pqid></control><display><type>article</type><title>Does a symptom management intervention affect depression among cancer patients: Results from a clinical trial</title><source>MEDLINE</source><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><source>Wiley Online Library All Journals</source><creator>Given, Charles ; Given, Barbara ; Rahbar, Mohammad ; Jeon, Sangchoon ; McCorkle, Ruth ; Cimprich, Bernadine ; Galecki, Andrez ; Kozachik, Sharon ; Devoss, Danielle ; Brady, Albert ; Fisher-Malloy, Mary Jo ; Courtney, Kathy ; Bowie, Elizabeth</creator><creatorcontrib>Given, Charles ; Given, Barbara ; Rahbar, Mohammad ; Jeon, Sangchoon ; McCorkle, Ruth ; Cimprich, Bernadine ; Galecki, Andrez ; Kozachik, Sharon ; Devoss, Danielle ; Brady, Albert ; Fisher-Malloy, Mary Jo ; Courtney, Kathy ; Bowie, Elizabeth</creatorcontrib><description>Cancer patients diagnosed with solid tumors and undergoing a first course of chemotherapy were randomized to either conventional care or a 10 contact 20 week cognitive behavioral intervention designed to reduce emotional distress. Three hypotheses were tested. First, a test for a group effect found that patients in the intervention who entered the trial with higher symptom severity reported significantly lower depression at 10 but not 20 weeks. Patients in the experimental group who entered with higher depression were more depressed at 10 weeks than patients in the control group. The second hypothesis compared the intervention in two sub‐indices of symptom severity; one comprised of symptoms with a depressive component, the other of symptoms not associated with depression. The intervention was more effective in lowering depression at 10 weeks through an interaction with the non‐depressive symptom sub‐index. At 20 weeks, a significant main effect for the intervention on depression was observed. No interaction with either sub‐index was observed. The third hypothesis found no main or interaction effect between psychotropic drugs and the intervention. In conclusion, behavioral interventions may influence depression differently over time. Initially, the intervention lowered depression through certain symptoms and only later did it effect depression directly. Symptoms with an affective component are relatively unaffected by the intervention which was independent of the presence of psychotropic medications. Copyright © 2004 John Wiley &amp; Sons, Ltd.</description><identifier>ISSN: 1057-9249</identifier><identifier>EISSN: 1099-1611</identifier><identifier>DOI: 10.1002/pon.807</identifier><identifier>PMID: 15386790</identifier><identifier>CODEN: POJCEE</identifier><language>eng</language><publisher>Chichester, UK: John Wiley &amp; Sons, Ltd</publisher><subject>Adult ; Antineoplastic Agents - therapeutic use ; Cancer ; Chemotherapy ; Clinical outcomes ; Clinical trials ; Cognitive behaviour therapy ; Cognitive Therapy - methods ; Depression ; Depressive Disorder, Major - diagnosis ; Depressive Disorder, Major - epidemiology ; Female ; Humans ; Intervention ; Male ; Mental depression ; Neoplasms - drug therapy ; Neoplasms - epidemiology ; Neoplasms - psychology ; Neoplasms - therapy ; Patients ; Reduction ; USA</subject><ispartof>Psycho-oncology (Chichester, England), 2004-11, Vol.13 (11), p.818-830</ispartof><rights>Copyright © 2004 John Wiley &amp; Sons, Ltd.</rights><rights>Copyright (c) 2004 John Wiley &amp; Sons, Ltd.</rights><rights>Copyright John Wiley and Sons, Limited Nov 2004</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4417-a64d4d123c0fc7c0522c7d4268520e0b8e93d0491f02344058ed22a0516476b63</citedby><cites>FETCH-LOGICAL-c4417-a64d4d123c0fc7c0522c7d4268520e0b8e93d0491f02344058ed22a0516476b63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fpon.807$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fpon.807$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,30999,31000,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15386790$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Given, Charles</creatorcontrib><creatorcontrib>Given, Barbara</creatorcontrib><creatorcontrib>Rahbar, Mohammad</creatorcontrib><creatorcontrib>Jeon, Sangchoon</creatorcontrib><creatorcontrib>McCorkle, Ruth</creatorcontrib><creatorcontrib>Cimprich, Bernadine</creatorcontrib><creatorcontrib>Galecki, Andrez</creatorcontrib><creatorcontrib>Kozachik, Sharon</creatorcontrib><creatorcontrib>Devoss, Danielle</creatorcontrib><creatorcontrib>Brady, Albert</creatorcontrib><creatorcontrib>Fisher-Malloy, Mary Jo</creatorcontrib><creatorcontrib>Courtney, Kathy</creatorcontrib><creatorcontrib>Bowie, Elizabeth</creatorcontrib><title>Does a symptom management intervention affect depression among cancer patients: Results from a clinical trial</title><title>Psycho-oncology (Chichester, England)</title><addtitle>Psycho-Oncology</addtitle><description>Cancer patients diagnosed with solid tumors and undergoing a first course of chemotherapy were randomized to either conventional care or a 10 contact 20 week cognitive behavioral intervention designed to reduce emotional distress. Three hypotheses were tested. First, a test for a group effect found that patients in the intervention who entered the trial with higher symptom severity reported significantly lower depression at 10 but not 20 weeks. Patients in the experimental group who entered with higher depression were more depressed at 10 weeks than patients in the control group. The second hypothesis compared the intervention in two sub‐indices of symptom severity; one comprised of symptoms with a depressive component, the other of symptoms not associated with depression. The intervention was more effective in lowering depression at 10 weeks through an interaction with the non‐depressive symptom sub‐index. At 20 weeks, a significant main effect for the intervention on depression was observed. No interaction with either sub‐index was observed. The third hypothesis found no main or interaction effect between psychotropic drugs and the intervention. In conclusion, behavioral interventions may influence depression differently over time. Initially, the intervention lowered depression through certain symptoms and only later did it effect depression directly. Symptoms with an affective component are relatively unaffected by the intervention which was independent of the presence of psychotropic medications. Copyright © 2004 John Wiley &amp; Sons, Ltd.</description><subject>Adult</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Cancer</subject><subject>Chemotherapy</subject><subject>Clinical outcomes</subject><subject>Clinical trials</subject><subject>Cognitive behaviour therapy</subject><subject>Cognitive Therapy - methods</subject><subject>Depression</subject><subject>Depressive Disorder, Major - diagnosis</subject><subject>Depressive Disorder, Major - epidemiology</subject><subject>Female</subject><subject>Humans</subject><subject>Intervention</subject><subject>Male</subject><subject>Mental depression</subject><subject>Neoplasms - drug therapy</subject><subject>Neoplasms - epidemiology</subject><subject>Neoplasms - psychology</subject><subject>Neoplasms - therapy</subject><subject>Patients</subject><subject>Reduction</subject><subject>USA</subject><issn>1057-9249</issn><issn>1099-1611</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><recordid>eNqF0dFqFDEUBuAgiq2r-AYSvNALmXqSySQzvZNq19KyLaJ4GbKZMyV1JjMmGXXfvll3sVBQr3IIHz85-Ql5zuCIAfC30-iPalAPyCGDpimYZOzhdq5U0XDRHJAnMd4AZNvIx-SAVWUtVQOHZHg_YqSGxs0wpXGgg_HmGgf0iTqfMPzIkxs9NV2HNtEWp4Ax_r4ZRn9NrfEWA51MclnGY_oJ49ynSLuQ0wy1vfPOmp6m4Ez_lDzqTB_x2f5ckC-nHz6ffCwuLpdnJ-8uCisEU4WRohUt46WFzioLFedWtYLLuuKAsK6xKVsQDeuAl0JAVWPLuYGKSaHkWpYL8nqXO4Xx-4wx6cFFi31vPI5z1EoKXkrgdZav_imlyj_Gm-q_sFKsZtvYBXl5D96Mc_B5Xc05V7IEUd890IYxxoCdnoIbTNhoBnrbqM6N6txoli_2cfN6wPbO7SvM4M0O_HQ9bv6Wo68uV7u4YqddTPjrjzbhW161VJX-ulpqJa7Y8vx8pVV5C5T_t3w</recordid><startdate>200411</startdate><enddate>200411</enddate><creator>Given, Charles</creator><creator>Given, Barbara</creator><creator>Rahbar, Mohammad</creator><creator>Jeon, Sangchoon</creator><creator>McCorkle, Ruth</creator><creator>Cimprich, Bernadine</creator><creator>Galecki, Andrez</creator><creator>Kozachik, Sharon</creator><creator>Devoss, Danielle</creator><creator>Brady, Albert</creator><creator>Fisher-Malloy, Mary Jo</creator><creator>Courtney, Kathy</creator><creator>Bowie, Elizabeth</creator><general>John Wiley &amp; Sons, Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope><scope>ASE</scope><scope>FPQ</scope><scope>K6X</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>200411</creationdate><title>Does a symptom management intervention affect depression among cancer patients: Results from a clinical trial</title><author>Given, Charles ; Given, Barbara ; Rahbar, Mohammad ; Jeon, Sangchoon ; McCorkle, Ruth ; Cimprich, Bernadine ; Galecki, Andrez ; Kozachik, Sharon ; Devoss, Danielle ; Brady, Albert ; Fisher-Malloy, Mary Jo ; Courtney, Kathy ; Bowie, Elizabeth</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4417-a64d4d123c0fc7c0522c7d4268520e0b8e93d0491f02344058ed22a0516476b63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adult</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Cancer</topic><topic>Chemotherapy</topic><topic>Clinical outcomes</topic><topic>Clinical trials</topic><topic>Cognitive behaviour therapy</topic><topic>Cognitive Therapy - methods</topic><topic>Depression</topic><topic>Depressive Disorder, Major - diagnosis</topic><topic>Depressive Disorder, Major - epidemiology</topic><topic>Female</topic><topic>Humans</topic><topic>Intervention</topic><topic>Male</topic><topic>Mental depression</topic><topic>Neoplasms - drug therapy</topic><topic>Neoplasms - epidemiology</topic><topic>Neoplasms - psychology</topic><topic>Neoplasms - therapy</topic><topic>Patients</topic><topic>Reduction</topic><topic>USA</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Given, Charles</creatorcontrib><creatorcontrib>Given, Barbara</creatorcontrib><creatorcontrib>Rahbar, Mohammad</creatorcontrib><creatorcontrib>Jeon, Sangchoon</creatorcontrib><creatorcontrib>McCorkle, Ruth</creatorcontrib><creatorcontrib>Cimprich, Bernadine</creatorcontrib><creatorcontrib>Galecki, Andrez</creatorcontrib><creatorcontrib>Kozachik, Sharon</creatorcontrib><creatorcontrib>Devoss, Danielle</creatorcontrib><creatorcontrib>Brady, Albert</creatorcontrib><creatorcontrib>Fisher-Malloy, Mary Jo</creatorcontrib><creatorcontrib>Courtney, Kathy</creatorcontrib><creatorcontrib>Bowie, Elizabeth</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Psycho-oncology (Chichester, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Given, Charles</au><au>Given, Barbara</au><au>Rahbar, Mohammad</au><au>Jeon, Sangchoon</au><au>McCorkle, Ruth</au><au>Cimprich, Bernadine</au><au>Galecki, Andrez</au><au>Kozachik, Sharon</au><au>Devoss, Danielle</au><au>Brady, Albert</au><au>Fisher-Malloy, Mary Jo</au><au>Courtney, Kathy</au><au>Bowie, Elizabeth</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Does a symptom management intervention affect depression among cancer patients: Results from a clinical trial</atitle><jtitle>Psycho-oncology (Chichester, England)</jtitle><addtitle>Psycho-Oncology</addtitle><date>2004-11</date><risdate>2004</risdate><volume>13</volume><issue>11</issue><spage>818</spage><epage>830</epage><pages>818-830</pages><issn>1057-9249</issn><eissn>1099-1611</eissn><coden>POJCEE</coden><abstract>Cancer patients diagnosed with solid tumors and undergoing a first course of chemotherapy were randomized to either conventional care or a 10 contact 20 week cognitive behavioral intervention designed to reduce emotional distress. Three hypotheses were tested. First, a test for a group effect found that patients in the intervention who entered the trial with higher symptom severity reported significantly lower depression at 10 but not 20 weeks. Patients in the experimental group who entered with higher depression were more depressed at 10 weeks than patients in the control group. The second hypothesis compared the intervention in two sub‐indices of symptom severity; one comprised of symptoms with a depressive component, the other of symptoms not associated with depression. The intervention was more effective in lowering depression at 10 weeks through an interaction with the non‐depressive symptom sub‐index. At 20 weeks, a significant main effect for the intervention on depression was observed. No interaction with either sub‐index was observed. The third hypothesis found no main or interaction effect between psychotropic drugs and the intervention. In conclusion, behavioral interventions may influence depression differently over time. Initially, the intervention lowered depression through certain symptoms and only later did it effect depression directly. Symptoms with an affective component are relatively unaffected by the intervention which was independent of the presence of psychotropic medications. Copyright © 2004 John Wiley &amp; Sons, Ltd.</abstract><cop>Chichester, UK</cop><pub>John Wiley &amp; Sons, Ltd</pub><pmid>15386790</pmid><doi>10.1002/pon.807</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1057-9249
ispartof Psycho-oncology (Chichester, England), 2004-11, Vol.13 (11), p.818-830
issn 1057-9249
1099-1611
language eng
recordid cdi_proquest_miscellaneous_764236028
source MEDLINE; Applied Social Sciences Index & Abstracts (ASSIA); Wiley Online Library All Journals
subjects Adult
Antineoplastic Agents - therapeutic use
Cancer
Chemotherapy
Clinical outcomes
Clinical trials
Cognitive behaviour therapy
Cognitive Therapy - methods
Depression
Depressive Disorder, Major - diagnosis
Depressive Disorder, Major - epidemiology
Female
Humans
Intervention
Male
Mental depression
Neoplasms - drug therapy
Neoplasms - epidemiology
Neoplasms - psychology
Neoplasms - therapy
Patients
Reduction
USA
title Does a symptom management intervention affect depression among cancer patients: Results from a clinical trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T09%3A46%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Does%20a%20symptom%20management%20intervention%20affect%20depression%20among%20cancer%20patients:%20Results%20from%20a%20clinical%20trial&rft.jtitle=Psycho-oncology%20(Chichester,%20England)&rft.au=Given,%20Charles&rft.date=2004-11&rft.volume=13&rft.issue=11&rft.spage=818&rft.epage=830&rft.pages=818-830&rft.issn=1057-9249&rft.eissn=1099-1611&rft.coden=POJCEE&rft_id=info:doi/10.1002/pon.807&rft_dat=%3Cproquest_cross%3E67096295%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=222763048&rft_id=info:pmid/15386790&rfr_iscdi=true